作者：叶世青1，郭夏晴1，桂雄斌2，许斌2，俞渊2，古石靖1

单位：1.广西中医药大学，广西 南宁 530023； 2.广西中医药大学第一附属医院 肝胆外科，广西 南宁 530023

Authors: Ye Shiqing1, Guo Xiaqing1, Gui Xiongbin2, Xu Bin2, Yu Yuan2, Gu Shijing1

Unit:  1.Guangxi University of Chinese Medicine, Nanning 530023, Guangxi, China； 2.Hepatological Surgery Department, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, Guangxi, China

摘要：

原发性肝细胞癌(简称肝癌)是常见的恶性肿瘤,在中国发病率高,预后差,严重影响人民群众身体健康。目前临床上肝癌的治疗方法较多,但大部分患者就诊时已无法获得根治性治疗,所以总体治疗效果欠佳,且传统的肿瘤手术切除和肝移植对患者损伤较大,术后容易复发,单纯靶向治疗及免疫治疗效果尚未令人满意,经肝动脉化疗栓塞、射频消融、微波消融等介入治疗方式已经成为肝癌重要的治疗手段,具有创伤性较小、治疗时间短、恢复快及可重复性强等特点,经过多年的临床实践和研究已经得到证实。随着近年来医疗技术的不断创新发展,越来越多的小肝癌包括微小肝癌得以早期发现,为介入治疗提供了更加广阔的舞台,患者有更多的治疗选择。本文就肝癌介入治疗的最新研究进展作如下综述。

关键词：原发性肝癌; 介入治疗; 进展

Abstract：

Hepatocellular carcinoma (HCC) is a common malignancy. Its incidence rate has been high in China, with poor prognosis and incredible danger, seriously affecting people's health. At present, although there are many treatment options for HCC, most patients are not indicated for curative treatments due to late-stage diagnosis at their first visit to the doctor. Therefore, the general therapeutic results are not satisfactory. Hepatic resection and liver transplantation are more damaging to patients and have a high recurrence rate. Interventional procedures such as transhepatic artery chemoembolization, radiofrequency ablation, and microwave ablation have become essential therapies for patients with HCC. Through years of clinical practice and research, they are proved to be minimally invasive techniques requiring shorter operation time, enabling quick recovery of patients. With the continuous innovation and development of medical technology in recent years, more and more small HCC detected at an early stage allows a broader range of interventional treatment options for patients. This article reviews the latest research progress of interventional therapies for HCC as follows.

Key Words:  Primary liver cancer; Interventional therapy; Progress